Why Infrastructure and Industry Collaboration are Key to Australia’s Genomic Future We are living in a transformative moment for healthcare. As InGeNA CEO Dr Erin Evans recently highlighted in the Herald Sun, we are moving away from a general approach and...
Board Update We are excited to announce the appointment of two new Independent Directors. Following an extensive search and interviews with a number of highly qualified candidates InGeNA’s board are pleased to announce we have selected Monica Ferrie and Sandra...
2025’s Gene Therapy Breakthroughs Show the Future of Genomics in Action A new era of precision medicine is taking shape with remarkable speed, and few recent developments exemplify this better than the success of CRISPR-based and gene therapy interventions for rare...
InGeNA welcomes our new member VCGS VCGS (Victorian Clinical Genetics Services) are Australian experts in genetic testing. VCGS supports children, adults and families who are living with a genetic condition, or who want to understand their chance of developing one....
InGeNA welcomes our new partner CCRM CCRM Australia is a not-for-profit organisation working to accelerate the development, translation and commercialisation of regenerative medicine and advanced therapies in Australia. Leveraging national and international...
InGeNA CEO Appointed to Genomics Australia Advisory Council We’re proud to share that InGeNA CEO Dr Erin Evans has been appointed as one of seven individual members of the newly formed Genomics Australia Advisory Council, chaired by the Genomics Commissioner Tiffany...
